• Join
  • Login
  • Contact

Search abstracts

A description of how and why EPAs were developed in the Netherlands and the USA

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Presentation
  • By: WESTEIN, Marnix (KNMP, The Netherlands)
  • Co-author(s): Marnix Westein:,Knmp - Royal Dutch Pharmacists Association,Den Haag,Netherlands;Utrecht Institute of Pharmaceutical Sciences,Utrecht University,Utrecht,Netherlands
  • Abstract:

    The abstract has already been submitted by Amy Pittenger and/or Lucinda Maine.


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses